In pursuance of Reg 30 and Reg 33 of SEBI (LODR) Regulations 2015, the Board of Directors at its meeting held on Feb 11, 2026 have approved the following item. Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.7 pts less than Nifty Microcap 250 and 8.3 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chennai Meenakshi Multispeciality Hospital reported unaudited results for Q3 FY26 with revenue from operations of Rs. 911.13 lakhs, up from Rs. 882.84 lakhs in the same quarter last year. For the nine months ended December 2025, total income rose to Rs. 2,810.70 lakhs from Rs. 2,608.10 lakhs in the prior-year period, a growth of about 7.7%. However, the company continues to post losses, though narrowing — Q3 loss after tax was Rs. 54.06 lakhs (vs Rs. 62.95 lakhs last year) and the nine-month loss was Rs. 108.75 lakhs (vs Rs. 168.66 lakhs last year). Basic EPS stood at Rs. -1.46 for the nine-month period, improving from Rs. -2.26 a year ago. The statutory auditor (Elias George & Co.) issued an unqualified limited review report with no qualifications or emphasis of matter.
Losses are shrinking and operating margins are improving, but the company is still loss-making with negative reserves of Rs. 935.62 lakhs — meaning accumulated losses exceed share capital. Investors should note the continuing bottom-line losses despite revenue growth, though the trajectory is positive.